Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Taiwan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20191
20201
20223
20232
20243
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed3
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics3
Boehringer Ingelheim2
Bristol-Myers Squibb2
Insmed Incorporated2
Taichung Veterans General Hospital2
Celgene1
China Medical University Hospital1
Contineum Therapeutics1
Kyntra Bio1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial16
Idiopathic Pulmonary Fibrosis6
Pulmonary Fibrosis6
Idiopathic Interstitial Pneumonias3
Connective Tissue Diseases2
Fibrosis2
Hypertension, Pulmonary2
Arthritis, Rheumatoid1
Dermatomyositis1
Lung Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.